Keri Kratofil, PharmD., is a trailblazer in healthcare leadership and innovation, with a legacy of transformative achievements that have reshaped the industry. With a career marked by exceptional milestones, Dr. Kratofil has successfully driven over $5.9 billion in revenue across multiple organizations while pioneering groundbreaking initiatives such as the first nationwide COVID-19/Flu test and treat program led by pharmacists. Her visionary leadership has consistently pushed the boundaries of what’s possible, from creating new revenue streams to enhancing patient care through innovative medication management protocols. Keri’s ability to think strategically, foster collaboration, and implement data-driven solutions has not only achieved remarkable business growth but also elevated the pharmacy profession and community health on a national scale.

As an influential CEO with an entrepreneurial spirit, Dr. Kratofil advocates for advancing healthcare access. Her impact extends far beyond the boardroom. She has spearheaded initiatives that have delivered millions in charitable care, strengthened partnerships with diverse community organizations, and addressed critical social issues like food and housing insecurity. Her passion for fostering equitable healthcare and empowering teams to thrive has earned her prestigious accolades, including the 2024 South Florida Business Journal Influential Business Women Award. A dynamic speaker and thought leader, Dr. Kratofil inspires audiences by sharing her insights on leadership, innovation, and creating meaningful change. Her commitment to excellence and unwavering dedication to her community make her stand out.